Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Oludamilola Akinmolayemi"'
Autor:
Oludamilola Akinmolayemi, Suzanne Saldanha, Parag H Joshi, Sneha Deodhar, Colby R Ayers, Ian J Neeland, Anand Rohatgi
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257574 (2021)
Metabolic syndrome (MetS) is characterized by adiposity and atherogenic dyslipidemia consisting of elevated triglyceride and decreased high density lipoprotein cholesterol (HDL-C) levels however, cholesterol concentration alone does not reflect HDL f
Externí odkaz:
https://doaj.org/article/80b29ff62df94e249b987cb2848c3a55
Publikováno v:
JACC. Cardiovascular imaging. 16(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::893ab62871e44213d540a13ffbbe3631
https://pubmed.ncbi.nlm.nih.gov/36599564
https://pubmed.ncbi.nlm.nih.gov/36599564
Publikováno v:
JACC: Cardiovascular Imaging. 16:139-140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9831b232e88f3290b9c937b1efd15723
https://doi.org/10.1016/j.jcmg.2022.11.007
https://doi.org/10.1016/j.jcmg.2022.11.007
Autor:
Yu Zuo, Sherwin Navaz, Wenying Liang, Chun Li, Colby R. Ayers, Christine E. Rysenga, Alyssa Harbaugh, Gary L. Norman, E. Blair Solow, Bonnie Bermas, Oludamilola Akinmolayemi, Anand Rohatgi, David R. Karp, Jason S. Knight, James A. de Lemos
Publikováno v:
JAMA Network Open. 6:e236530
ImportanceThe prevalence of antiphospholipid antibodies (aPL) and their association with future atherosclerotic cardiovascular disease (ASCVD) risk has yet to be thoroughly investigated.ObjectiveTo determine the association between measurements of aP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::944f46bdb361426bd1b5c36451ad083b
https://doi.org/10.1001/jamanetworkopen.2023.6530
https://doi.org/10.1001/jamanetworkopen.2023.6530
Autor:
William A Clarkson, Jacob L Barber, Bridget Armstrong, Yuan Wang, Fiona C McGillicuddy, Suzanne Saldanha, Oludamilola Akinmolayemi, Ian J Neeland, Anand Rohatgi, Mark A Sarzynski
Publikováno v:
Circulation. 145
Introduction: While high-density lipoprotein (HDL) cholesterol is a component of metabolic syndrome, an ASCVD risk factor, other markers of HDL metabolism better associate with ASCVD. However, it is unclear whether these markers better discriminate b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83f8b97d0caa12e55fa8c349e65481c7
https://doi.org/10.1161/circ.145.suppl_1.p175
https://doi.org/10.1161/circ.145.suppl_1.p175
Autor:
Oludamilola Akinmolayemi, Mahesh Madhavan, Oluseun O. Alli, D. Edmund Anstey, Bjorn Redfors, Shmuel Chen, Bahira Shahim, William T. Abraham, JoAnn Lindenfeld, Michael J. Mack, Gregg W. Stone
Publikováno v:
Journal of the American College of Cardiology. 81:1086
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::363ca25c9ae32ab99912100ed929ec1f
https://doi.org/10.1016/s0735-1097(23)01530-9
https://doi.org/10.1016/s0735-1097(23)01530-9
Autor:
Oludamilola Akinmolayemi, Denizhan Ozdemir, Philippe Pibarot, Yanglu Zhao, Jonathon Leipsic, Pamela S. Douglas, Wael A. Jaber, Neil J. Weissman, Philipp Blanke, Rebecca T. Hahn
Publikováno v:
JACC. Cardiovascular imaging. 16(1)
Current expected normal echocardiographic measures of transcatheter heart valve (THV) function were derived from pooled cohorts of the randomized trials; however, THV function by flow state before or following transcatheter aortic valve replacement (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::497c5e829ca2637b20f2360c0d061bb0
https://pubmed.ncbi.nlm.nih.gov/36599555
https://pubmed.ncbi.nlm.nih.gov/36599555
Autor:
Kayla A. Riggs, Amit Khera, Anand Rohatgi, Colby Ayers, Oludamilola Akinmolayemi, Parag H. Joshi, Kavisha Singh
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 8; Issue 12; Pages: 2137
Journal of Clinical Medicine; Volume 8; Issue 12; Pages: 2137
High-density lipoproteins (HDL) exert anti-atherosclerotic effects via reverse cholesterol transport, yet this salutary property is impaired in the setting of inflammation. GlycA, a novel integrated glycosylation marker of five acute phase reactants,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d185800453d02a4b2d09cebf876434f
https://doi.org/10.3390/jcm8122137
https://doi.org/10.3390/jcm8122137